(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 18143.50 | 16384.40 | 10.74 | 73367.50 | 66779.20 | 9.87 | 73367.50 | 66779.20 | 9.87 |
| Other Income | 298.80 | 214.90 | 39.04 | 946.40 | 712.90 | 32.75 | 946.40 | 712.90 | 32.75 |
| PBIDT | 4610.60 | 3800.80 | 21.31 | 18749.30 | 15963.20 | 17.45 | 18749.30 | 15963.20 | 17.45 |
| Interest | 104.80 | 162.00 | -35.31 | 435.10 | 630.40 | -30.98 | 435.10 | 630.40 | -30.98 |
| PBDT | 4201.60 | 823.40 | 410.27 | 18010.00 | 12517.40 | 43.88 | 18010.00 | 12517.40 | 43.88 |
| Depreciation | 703.10 | 651.90 | 7.85 | 2688.70 | 2519.70 | 6.71 | 2688.70 | 2519.70 | 6.71 |
| PBT | 3498.50 | 171.50 | 1939.94 | 15321.30 | 9997.70 | 53.25 | 15321.30 | 9997.70 | 53.25 |
| TAX | 875.60 | 822.00 | 6.52 | 3996.10 | 3490.10 | 14.50 | 3996.10 | 3490.10 | 14.50 |
| Deferred Tax | -65.50 | 63.00 | -203.97 | -25.10 | 81.10 | -130.95 | -25.10 | 81.10 | -130.95 |
| PAT | 2622.90 | -650.50 | -503.21 | 11325.20 | 6507.60 | 74.03 | 11325.20 | 6507.60 | 74.03 |
| Equity | 253.70 | 253.70 | 0.00 | 253.70 | 253.70 | 0.00 | 253.70 | 253.70 | 0.00 |
| PBIDTM(%) | 25.41 | 23.20 | 9.54 | 25.56 | 23.90 | 6.91 | 25.56 | 23.90 | 6.91 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: